MyFinsight
Home
Blog
About
Contact
Back
Income Statement
TScan Therapeutics, Inc. (TCRX)
TScan Therapeutics, Inc. (TCRX)
source: myfinsight.com
Download
Download image
Comprehensive loss
-$28,666K
Interest and other
income, net
$1,162K
(-58.53%↓ Y/Y)
Net loss
-$28,666K
(16.00%↑ Y/Y)
Total other income
$473K
(-77.72%↓ Y/Y)
Interest expense
$689K
(1.47%↑ Y/Y)
Loss from operations
-$29,139K
(19.62%↑ Y/Y)
Collaboration and license
revenue
$982K
(-54.77%↓ Y/Y)
Total operating
expenses
$30,121K
(-21.60%↓ Y/Y)
Research and development
$21,904K
(-26.47%↓ Y/Y)
General and
administrative
$8,217K
(-4.82%↓ Y/Y)
Back